Arch Venture Corp
Latest statistics and disclosures from ARCH Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RAPP, BEAM, MAZE, VIR, LYEL, and represent 90.65% of ARCH Venture Management's stock portfolio.
- Added to shares of these 1 stock: LYEL (+$15M).
- Reduced shares in these 2 stocks: VERV (-$23M), Unity Biotechnology.
- Sold out of its positions in Unity Biotechnology, VERV.
- ARCH Venture Management was a net seller of stock by $-7.7M.
- ARCH Venture Management has $492M in assets under management (AUM), dropping by 64.61%.
- Central Index Key (CIK): 0001274403
Tip: Access up to 7 years of quarterly data
Positions held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rapport Therapeutics (RAPP) | 22.5 | $111M | 3.7M | 29.70 |
|
|
| Beam Therapeutics (BEAM) | 22.4 | $110M | 4.5M | 24.27 |
|
|
| Maze Therapeatics (MAZE) | 21.7 | $107M | 4.1M | 25.93 |
|
|
| Vir Biotechnology (VIR) | 15.0 | $74M | 13M | 5.71 |
|
|
| Lyell Immunopharma Com New (LYEL) | 9.1 | $45M | +51% | 2.8M | 16.24 |
|
| Erasca (ERAS) | 4.9 | $24M | 11M | 2.18 |
|
|
| Gossamer Bio (GOSS) | 4.3 | $21M | 8.1M | 2.63 |
|
|
| Q32 Bio (QTTB) | 0.1 | $635k | 321k | 1.98 |
|
|
| Cero Therapeutics Hldgs (CERO) | 0.0 | $114k | 22k | 5.09 |
|
Past Filings by ARCH Venture Management
SEC 13F filings are viewable for ARCH Venture Management going back to 2018
- ARCH Venture Management 2025 Q3 filed Nov. 14, 2025
- ARCH Venture Management 2025 Q2 filed Aug. 14, 2025
- ARCH Venture Management 2025 Q1 filed May 15, 2025
- ARCH Venture Management 2024 Q4 filed Feb. 14, 2025
- ARCH Venture Management 2024 Q3 filed Nov. 14, 2024
- ARCH Venture Management 2024 Q2 filed Aug. 14, 2024
- ARCH Venture Management 2024 Q1 filed May 15, 2024
- ARCH Venture Management 2023 Q4 filed Feb. 14, 2024
- ARCH Venture Management 2023 Q3 filed Nov. 14, 2023
- ARCH Venture Management 2023 Q2 filed Aug. 9, 2023
- ARCH Venture Management 2023 Q1 filed May 15, 2023
- ARCH Venture Management 2022 Q4 filed Feb. 14, 2023
- ARCH Venture Management 2022 Q3 filed Nov. 10, 2022
- ARCH Venture Management 2022 Q2 filed Aug. 15, 2022
- ARCH Venture Management 2022 Q1 restated filed May 27, 2022
- ARCH Venture Management 2022 Q1 filed May 13, 2022